News
Most drivers know that they should have a complete emergency kit in their vehicles. This is incredibly handy when something ...
3d
Space.com on MSNNew moon of April 2025 sees Venus and Saturn join up in the sky this weekendThe new moon occurs April 27, and a day later Venus and Saturn will make a close approach to each other (known as a ...
Alongside a crescent moon, Mercury, Venus and Saturn will become visible to stargazers just before dawn on Friday morning.
In a report released yesterday, Lili (Aurélie) Nsongo from Leerink Partners maintained a Hold rating on Arcturus Therapeutics ( ARCT – Research Report ), with a price target of $63.00. Discover ...
The two brightest nighttime stars visible in the Pottsville sky are Sirius and Arcturus. April is the only month of the year when we can enjoy both of them at the same time in the early evening ...
Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying mRNA (sa-mRNA) vaccine candidate, ARCT-2304, for active immunization to ...
The two brightest nighttime stars available in the Shamokin sky are Sirius and Arcturus. April is the only month of the year we can enjoy both of them at the same time in the early evening ...
SAN DIEGO - Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a biotechnology firm specializing in mRNA medicines with a market capitalization of $266 million, announced today that the U.S. Food and ...
Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate. Arcturus on Thursday said the designation ...
Guggenheim analyst Seamus Fernandez lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $45 from $71 and keeps a Buy rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results